Serum hepatokines in dairy cows: periparturient variation and changes in energy-related metabolic disorders

Abstract Background During peripartum period, dairy cows are highly susceptible to energy metabolism disorders such as fatty liver and ketosis. Angiopoietin-like protein 4 (ANGPTL4) and fibroblast growth factor 21 (FGF21), known as hepatokines, play important roles in lipid metabolism. The purposes...

Full description

Bibliographic Details
Main Authors: Jianguo Wang, Xiaoyan Zhu, Guanghui She, Yezi Kong, Yazhou Guo, Zhe Wang, Guowen Liu, Baoyu Zhao
Format: Article
Language:English
Published: BMC 2018-08-01
Series:BMC Veterinary Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12917-018-1560-7
id doaj-30696256a07542ba9751e3cce5598601
record_format Article
spelling doaj-30696256a07542ba9751e3cce55986012020-11-25T02:39:31ZengBMCBMC Veterinary Research1746-61482018-08-011411910.1186/s12917-018-1560-7Serum hepatokines in dairy cows: periparturient variation and changes in energy-related metabolic disordersJianguo Wang0Xiaoyan Zhu1Guanghui She2Yezi Kong3Yazhou Guo4Zhe Wang5Guowen Liu6Baoyu Zhao7College of Veterinary Medicine, Northwest A&F UniversityCollege of Veterinary Medicine, Northwest A&F UniversityCollege of Veterinary Medicine, Northwest A&F UniversityCollege of Veterinary Medicine, Northwest A&F UniversityCollege of Veterinary Medicine, Northwest A&F UniversityCollege of Veterinary Medicine, Jilin UniversityCollege of Veterinary Medicine, Jilin UniversityCollege of Veterinary Medicine, Northwest A&F UniversityAbstract Background During peripartum period, dairy cows are highly susceptible to energy metabolism disorders such as fatty liver and ketosis. Angiopoietin-like protein 4 (ANGPTL4) and fibroblast growth factor 21 (FGF21), known as hepatokines, play important roles in lipid metabolism. The purposes of our study were to evaluate variations of serum ANGPTL4 and FGF21 concentrations in periparturient dairy cows and changes in these serum analyte concentrations of energy-related metabolic disorders in early lactation dairy cows. This study was divided into two experiments. Experiment I: Blood parameters were measured in healthy periparturient Holstein cows from 4 wk antepartum to 4 wk postpartum (n = 219). In this experiment, weekly blood samples were obtained from 4 wk before the expected calving date through 4 wk after calving. Experiment II: Blood parameters were measured in healthy cows (n = 30) and cows with clinical ketosis (n = 29) and fatty liver (n = 25) within the first 4 wk of lactation. In the present study, all blood samples were collected from the coccygeal vein in the early morning before feeding. Results Serum ANGPTL4 and FGF21 concentrations peaked at parturition, and declined rapidly over the following 2 wk Serum ANGPTL4 and FGF21 concentrations were positively correlated with serum non-esterified fatty acids (NEFA) concentration (r = 0.856, P = 003; r = 0.848, P = 0.004, respectively). Cows with clinical ketosis and fatty liver had significantly higher serum ANGPTL4 and FGF21 concentrations than healthy cows (P < 0.01). Conclusion Serum ANGPTL4 and FGF21 concentrations were elevated during peripartum period, suggesting that energy balance changes that were associated with parturition contributed significantly to these effects. Although FGF21 and ANGPTL4 could play important roles in the adaptation of energy metabolism, they may be involved in the pathological processes of energy metabolism disorders of dairy cows in the peripartum period.http://link.springer.com/article/10.1186/s12917-018-1560-7Dairy cowPeripartum periodAngiopoietin-like protein 4Fibroblast growth factor 21Energy metabolism disorder
collection DOAJ
language English
format Article
sources DOAJ
author Jianguo Wang
Xiaoyan Zhu
Guanghui She
Yezi Kong
Yazhou Guo
Zhe Wang
Guowen Liu
Baoyu Zhao
spellingShingle Jianguo Wang
Xiaoyan Zhu
Guanghui She
Yezi Kong
Yazhou Guo
Zhe Wang
Guowen Liu
Baoyu Zhao
Serum hepatokines in dairy cows: periparturient variation and changes in energy-related metabolic disorders
BMC Veterinary Research
Dairy cow
Peripartum period
Angiopoietin-like protein 4
Fibroblast growth factor 21
Energy metabolism disorder
author_facet Jianguo Wang
Xiaoyan Zhu
Guanghui She
Yezi Kong
Yazhou Guo
Zhe Wang
Guowen Liu
Baoyu Zhao
author_sort Jianguo Wang
title Serum hepatokines in dairy cows: periparturient variation and changes in energy-related metabolic disorders
title_short Serum hepatokines in dairy cows: periparturient variation and changes in energy-related metabolic disorders
title_full Serum hepatokines in dairy cows: periparturient variation and changes in energy-related metabolic disorders
title_fullStr Serum hepatokines in dairy cows: periparturient variation and changes in energy-related metabolic disorders
title_full_unstemmed Serum hepatokines in dairy cows: periparturient variation and changes in energy-related metabolic disorders
title_sort serum hepatokines in dairy cows: periparturient variation and changes in energy-related metabolic disorders
publisher BMC
series BMC Veterinary Research
issn 1746-6148
publishDate 2018-08-01
description Abstract Background During peripartum period, dairy cows are highly susceptible to energy metabolism disorders such as fatty liver and ketosis. Angiopoietin-like protein 4 (ANGPTL4) and fibroblast growth factor 21 (FGF21), known as hepatokines, play important roles in lipid metabolism. The purposes of our study were to evaluate variations of serum ANGPTL4 and FGF21 concentrations in periparturient dairy cows and changes in these serum analyte concentrations of energy-related metabolic disorders in early lactation dairy cows. This study was divided into two experiments. Experiment I: Blood parameters were measured in healthy periparturient Holstein cows from 4 wk antepartum to 4 wk postpartum (n = 219). In this experiment, weekly blood samples were obtained from 4 wk before the expected calving date through 4 wk after calving. Experiment II: Blood parameters were measured in healthy cows (n = 30) and cows with clinical ketosis (n = 29) and fatty liver (n = 25) within the first 4 wk of lactation. In the present study, all blood samples were collected from the coccygeal vein in the early morning before feeding. Results Serum ANGPTL4 and FGF21 concentrations peaked at parturition, and declined rapidly over the following 2 wk Serum ANGPTL4 and FGF21 concentrations were positively correlated with serum non-esterified fatty acids (NEFA) concentration (r = 0.856, P = 003; r = 0.848, P = 0.004, respectively). Cows with clinical ketosis and fatty liver had significantly higher serum ANGPTL4 and FGF21 concentrations than healthy cows (P < 0.01). Conclusion Serum ANGPTL4 and FGF21 concentrations were elevated during peripartum period, suggesting that energy balance changes that were associated with parturition contributed significantly to these effects. Although FGF21 and ANGPTL4 could play important roles in the adaptation of energy metabolism, they may be involved in the pathological processes of energy metabolism disorders of dairy cows in the peripartum period.
topic Dairy cow
Peripartum period
Angiopoietin-like protein 4
Fibroblast growth factor 21
Energy metabolism disorder
url http://link.springer.com/article/10.1186/s12917-018-1560-7
work_keys_str_mv AT jianguowang serumhepatokinesindairycowsperiparturientvariationandchangesinenergyrelatedmetabolicdisorders
AT xiaoyanzhu serumhepatokinesindairycowsperiparturientvariationandchangesinenergyrelatedmetabolicdisorders
AT guanghuishe serumhepatokinesindairycowsperiparturientvariationandchangesinenergyrelatedmetabolicdisorders
AT yezikong serumhepatokinesindairycowsperiparturientvariationandchangesinenergyrelatedmetabolicdisorders
AT yazhouguo serumhepatokinesindairycowsperiparturientvariationandchangesinenergyrelatedmetabolicdisorders
AT zhewang serumhepatokinesindairycowsperiparturientvariationandchangesinenergyrelatedmetabolicdisorders
AT guowenliu serumhepatokinesindairycowsperiparturientvariationandchangesinenergyrelatedmetabolicdisorders
AT baoyuzhao serumhepatokinesindairycowsperiparturientvariationandchangesinenergyrelatedmetabolicdisorders
_version_ 1724785691415543808